This study was designed to determine how well the combination medication, sumatriptan and
naproxen sodium, treats migraine headache in adolescents 12-17 years old
Minimum age: 12 Years.
Maximum age: 17 Years.
Gender(s): Both.
GSK Investigational Site, Gilbert, Arizona 85234, United States
GSK Investigational Site, Litchfield Park, Arizona 85340, United States
GSK Investigational Site, Phoenix, Arizona 85016, United States
GSK Investigational Site, Phoenix, Arizona 85013, United States
GSK Investigational Site, Phoenix, Arizona 85014, United States
GSK Investigational Site, Conway, Arkansas 72034, United States
GSK Investigational Site, Little Rock, Arkansas 72202, United States
GSK Investigational Site, Little Rock, Arkansas 72205, United States
GSK Investigational Site, Chico, California 95926, United States
GSK Investigational Site, Fresno, California 93720, United States
GSK Investigational Site, Fullteron, California 92835, United States
GSK Investigational Site, Huntington Beach, California 92647, United States
GSK Investigational Site, Newport Beach, California 92660, United States
GSK Investigational Site, Roseville, California 95678, United States
GSK Investigational Site, Sacramento, California 95815, United States
GSK Investigational Site, San Francisco, California 94109, United States
GSK Investigational Site, Santa Monica, California 90404, United States
GSK Investigational Site, Colorado Springs, Colorado 80907, United States
GSK Investigational Site, Fairfield, Connecticut 06824, United States
GSK Investigational Site, Gainesville, Florida 32607, United States
GSK Investigational Site, Hialeah, Florida 33010, United States
GSK Investigational Site, Miami, Florida 33155-3009, United States
GSK Investigational Site, West Palm Beach, Florida 33407, United States
GSK Investigational Site, Atlanta, Georgia 30342, United States
GSK Investigational Site, Savannah, Georgia 31405, United States
GSK Investigational Site, Stockbridge, Georgia 30281, United States
GSK Investigational Site, Chicago, Illinois 60642, United States
GSK Investigational Site, Oak Lawn, Illinois 60453, United States
GSK Investigational Site, Park Ridge, Illinois 60068, United States
GSK Investigational Site, Anderson, Indiana 46011, United States
GSK Investigational Site, Terre Haute, Indiana 47802, United States
GSK Investigational Site, Kansas City, Kansas 66160, United States
GSK Investigational Site, Wichita, Kansas 67207, United States
GSK Investigational Site, Bardstown, Kentucky 40004, United States
GSK Investigational Site, Lexington, Kentucky 40509, United States
GSK Investigational Site, Pikesville, Maryland 21208, United States
GSK Investigational Site, Worcester, Massachusetts 01605, United States
GSK Investigational Site, Ann Arbor, Michigan 48104, United States
GSK Investigational Site, Plymouth, Minnesota 55441, United States
GSK Investigational Site, Springfield, Missouri 65807, United States
GSK Investigational Site, St. Louis, Missouri 63141, United States
GSK Investigational Site, Omaha, Nebraska 68130, United States
GSK Investigational Site, Vorhees, New Jersey 08043, United States
GSK Investigational Site, Willingboro, New Jersey 08046, United States
GSK Investigational Site, Albuquerque, New Mexico 87108, United States
GSK Investigational Site, Amherst, New York 14226, United States
GSK Investigational Site, Mineola, New York 11501, United States
GSK Investigational Site, Mount Vernon, New York 10550, United States
GSK Investigational Site, Schenectady, New York 12308, United States
GSK Investigational Site, Raleigh, North Carolina 27607, United States
GSK Investigational Site, Cincinnati, Ohio 45229, United States
GSK Investigational Site, Cincinnati, Ohio 45245, United States
GSK Investigational Site, Cleveland, Ohio 44195, United States
GSK Investigational Site, West Chester, Ohio 45069, United States
GSK Investigational Site, Westerville, Ohio 43081, United States
GSK Investigational Site, Oklahoma City, Oklahoma 73112, United States
GSK Investigational Site, Eugene, Oregon 97401, United States
GSK Investigational Site, Portland, Oregon 97210, United States
GSK Investigational Site, Salem, Oregon 97301, United States
GSK Investigational Site, Philadelphia, Pennsylvania 19139, United States
GSK Investigational Site, Pittsburgh, Pennsylvania 15236, United States
GSK Investigational Site, Greer, South Carolina 29651, United States
GSK Investigational Site, Simpsonville, South Carolina 29681, United States
GSK Investigational Site, Bristol, Tennessee 37620, United States
GSK Investigational Site, Clarksville, Tennessee 37043, United States
GSK Investigational Site, Dallas, Texas 75230, United States
GSK Investigational Site, Houston, Texas 77030-2303, United States
GSK Investigational Site, San Antonio, Texas 78258, United States
GSK Investigational Site, Salt Lake City, Utah 84107, United States
GSK Investigational Site, Charlottesville, Virginia 22902, United States
GSK Investigational Site, Norfolk, Virginia 23510, United States
GSK Investigational Site, Seattle, Washington 98195-6097, United States
GSK Investigational Site, Vancouver, Washington 98686, United States
GSK Investigational Site, Wenatchee, Washington 98801, United States
GSK Investigational Site, Madison, Wisconsin 53715, United States
GSK Investigational Site, Middleton, Wisconsin 53562-2215, United States
Brandes JL, Kudrow D, Stark SR, O'Carroll CP, Adelman JU, O'Donnell FJ, Alexander WJ, Spruill SE, Barrett PS, Lener SE. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA. 2007 Apr 4;297(13):1443-54.